When selecting recombinant proteins, cell culture cytokines, growth factors, or biological raw materials, you will often encounter terms such as GMP, ISO 9001, ISO 13485, and FDA DMF in product descriptions. Many researchers and biotechnology companies ask the same questions:

• Is GMP a certification?

• Is ISO a lower-level standard than GMP?

• Does an FDA Drug Master File (DMF) mean the product has already been approved by the FDA?

• Which quality systems should researchers and biopharmaceutical developers really pay attention to?

In reality, these terms represent different aspects of quality management systems and regulatory compliance. They are not interchangeable, nor do they represent different "levels" of quality. Understanding the role of each quality system is essential for choosing reliable recombinant proteins, cell culture reagents, cytokines, and biopharmaceutical raw materials.

Let's explore the key differences.

1. GMP: Ensuring Consistent and Controlled Manufacturing

GMP (Good Manufacturing Practice) is a comprehensive quality management system designed to ensure that products are consistently manufactured and controlled according to predefined quality standards.

Unlike a single quality test, GMP focuses on the entire manufacturing process—from raw material sourcing and production to quality control, documentation, personnel training, equipment qualification, and batch traceability. Its primary objective is to ensure that every production batch is consistent, reproducible, and fully traceable.

In industries such as cell therapy, biopharmaceutical manufacturing, recombinant protein production, and regenerative medicine, GMP compliance is critical. It not only ensures product quality but also supports clinical trial applications, regulatory submissions, and commercial-scale manufacturing.

2. ISO: Building a Robust Quality Management System

ISO (International Organization for Standardization) develops internationally recognized quality management standards that focus on how an organization operates rather than on a specific product.For biotechnology and life science companies, the two most relevant standards are:

ISO 9001 – Quality Management System

ISO 9001 is the world's most widely adopted quality management standard.

It emphasizes:

• Document control

• Risk management

• Continuous improvement

• Customer satisfaction

• Process standardization

• Operational efficiency

Implementing ISO 9001 helps organizations establish a structured, efficient, and continuously improving quality management system.

ISO 13485 – Quality Management for Medical Devices

ISO 13485 is specifically developed for the medical device and in vitro diagnostic (IVD) industries.

In addition to the principles of ISO 9001, it introduces more stringent requirements related to:

• Regulatory compliance

• Risk management throughout the product lifecycle

• Design and development controls

• Product traceability

• Medical device documentation

For manufacturers of IVD raw materials, diagnostic reagents, recombinant proteins, antibodies, and other life science products, ISO 13485 is often an essential quality management standard.

3. FDA DMF: Supporting Regulatory Submissions

FDA DMF (Drug Master File) is one of the most commonly misunderstood regulatory terms.

Many people assume that:

Having an FDA DMF means the product has been approved by the FDA.

In reality, this is not true.

A Drug Master File is a confidential technical dossier voluntarily submitted to the U.S. Food and Drug Administration (FDA). It typically contains detailed information about:

• Manufacturing processes

• Raw materials

• Quality control procedures

• Analytical methods

• Stability data

• Packaging information

• Manufacturing facilities

The greatest value of an FDA DMF lies in regulatory support.

When customers submit an IND (Investigational New Drug Application), BLA (Biologics License Application), or other FDA regulatory filings, they can reference the supplier's DMF instead of resubmitting the complete technical documentation.

Therefore, an FDA DMF demonstrates a supplier's regulatory support capability, not FDA product approval.

4. Eastmabbio: Delivering High-Quality Recombinant Proteins Through Comprehensive Quality Systems

As a company dedicated to the research, development, and manufacturing of recombinant proteins, Eastmabbio integrates quality management throughout every stage of the product lifecycle.

Our quality system covers research and development, manufacturing, quality control, and product release, ensuring reliable performance and consistent product quality for both research and industrial applications.

Our quality capabilities include:

· GMP-compliant manufacturing practices

· ISO 9001 Quality Management System

· ISO 13485 Medical Device Quality Management System

· Regulatory support through 24+ FDA Drug Master Files (DMFs)

· Comprehensive QC testing procedures

· Full batch traceability

· Strict batch-to-batch consistency control

From early-stage scientific research to large-scale biopharmaceutical manufacturing, Dongkang Biotech is committed to providing high-quality recombinant proteins, cell culture cytokines, growth factors, and biological reagents backed by robust quality systems, regulatory expertise, and reliable technical support.

Whether you are developing cell therapies, biologics, vaccines, regenerative medicine products, or in vitro diagnostic (IVD) assays, choosing suppliers with strong quality management and regulatory capabilities can significantly reduce development risks and accelerate your path from research to commercialization.